共 137 条
[1]
Katz A(2013)Stereotactic body radiation therapy for low-, intermediate-, and high-risk prostate cancer: disease control and quality of life at 6 years Int J Radiat Oncol Biol Phys 87 S24-S25
[2]
Kang J(2011)Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes Radiat Oncol 6 1-5
[3]
Freeman DE(2013)Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes Radiother Oncol 107 153-8
[4]
King CR(2013)Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study Radiot Oncol 8 1-8
[5]
Loblaw A(2012)Prostate alpha/beta revisited − an analysis of clinical results from 14168 patients Acta Oncol 51 963-74
[6]
Cheung P(2012)Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: Int J Radiat Oncol Biol Phys 82 e17-24
[7]
D’Alimonte L(2014)/ Radiother Oncol 110 298-302
[8]
Deabreu A(2015) = 1.4 (0.92.2)Gy Pract Radiat Oncol 5 e489-97
[9]
Mamedov A(2015)Developing a class solution for prostate stereotactic ablative body radiotherapy (SABR) using volumetric modulated arc therapy (VMAT) Phys Med Biol 60 1237-57
[10]
Zhang L(2015)Stereotactic ablative radiation therapy with volumetric modulated arc therapy in flattening filter-free mode for low-, intermediate-, and high-risk prostate cancer patients: Are 2 arcs better than 1? J Appl Clin Med Phys 16 5728-62